
Sign up to save your podcasts
Or
Mairi McLean talks to Anna Paterson and Rebecca Fitzgerald, both MRC Cancer Cell Unit, Hutchison-MRC Research Centre, Cambridge, about their study investigating whether a receptor tyrosine kinase (RTK) array could be used to select the most effective therapeutic strategies in molecularly heterogeneous oesophago-gastric adenocarcinomas.
Read the full paper here: bit.ly/1acACwz
4.1
77 ratings
Mairi McLean talks to Anna Paterson and Rebecca Fitzgerald, both MRC Cancer Cell Unit, Hutchison-MRC Research Centre, Cambridge, about their study investigating whether a receptor tyrosine kinase (RTK) array could be used to select the most effective therapeutic strategies in molecularly heterogeneous oesophago-gastric adenocarcinomas.
Read the full paper here: bit.ly/1acACwz
129 Listeners
40 Listeners
4 Listeners
49 Listeners
4 Listeners
3 Listeners
1 Listeners
3 Listeners
315 Listeners
10 Listeners
40 Listeners
67 Listeners
14 Listeners
1 Listeners
34 Listeners
0 Listeners
6 Listeners
16 Listeners
481 Listeners
282 Listeners
3 Listeners
90 Listeners
33 Listeners
1,095 Listeners
173 Listeners
509 Listeners
23 Listeners
320 Listeners
243 Listeners
18 Listeners
15 Listeners
0 Listeners